Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon N Stacey

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Nature Genetics|February 12, 2008
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerJulius Gudmundsson, Patrick Sulem, Thorunn Rafnar, et al.
Nature Genetics|March 30, 2010
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancerLambertus A Kiemeney, Patrick Sulem, Soren Besenbacher, et al.
Human Molecular Genetics|July 14, 2011
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility geneThorunn Rafnar, Sita H Vermeulen, Patrick Sulem, et al.
Nature Genetics|July 3, 2007
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesJulius Gudmundsson, Patrick Sulem, Valgerdur Steinthorsdottir, et al.
Nature Genetics|January 20, 2009
Sequence variants at the TERT-CLPTM1L locus associate with many cancer typesThorunn Rafnar, Patrick Sulem, Simon N Stacey, et al.
Nature Genetics|March 5, 2013
A variant in FTO shows association with melanoma risk not due to BMIMark M Iles, Matthew H Law, Simon N Stacey, et al.
Nature Genetics|September 28, 2011
A germline variant in the TP53 polyadenylation signal confers cancer susceptibilitySimon N Stacey, Patrick Sulem, Aslaug Jonasdottir, et al.
Cancer Research|May 20, 2016
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic AssociationsGordon Fehringer, Peter Kraft, Paul D Pharoah, et al.
Nature Genetics|January 24, 2012
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathwaysLisette Stolk, John R B Perry, Daniel I Chasman, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Nature Genetics|February 12, 2008
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerJulius Gudmundsson, Patrick Sulem, Thorunn Rafnar, et al.
Nature Genetics|March 30, 2010
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancerLambertus A Kiemeney, Patrick Sulem, Soren Besenbacher, et al.
Human Molecular Genetics|July 14, 2011
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility geneThorunn Rafnar, Sita H Vermeulen, Patrick Sulem, et al.
Nature Genetics|July 3, 2007
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesJulius Gudmundsson, Patrick Sulem, Valgerdur Steinthorsdottir, et al.
Nature Genetics|January 20, 2009
Sequence variants at the TERT-CLPTM1L locus associate with many cancer typesThorunn Rafnar, Patrick Sulem, Simon N Stacey, et al.
Nature Genetics|March 5, 2013
A variant in FTO shows association with melanoma risk not due to BMIMark M Iles, Matthew H Law, Simon N Stacey, et al.
Nature Genetics|September 28, 2011
A germline variant in the TP53 polyadenylation signal confers cancer susceptibilitySimon N Stacey, Patrick Sulem, Aslaug Jonasdottir, et al.
Cancer Research|May 20, 2016
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic AssociationsGordon Fehringer, Peter Kraft, Paul D Pharoah, et al.
Nature Genetics|January 24, 2012
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathwaysLisette Stolk, John R B Perry, Daniel I Chasman, et al.
Pageof 6